$9.08
+0.21
(+2.37%)▲
3.47%
Downside
Day's Volatility :3.52%
Upside
0.06%
9.47%
Downside
52 Weeks Volatility :69.61%
Upside
66.43%
Period | Walgreens Boots Alliance, Inc. | Sector (Consumer Staples) | S&P500 |
---|---|---|---|
3 Months | -15.85% | 5.2% | 3.1% |
6 Months | -52.66% | 8.7% | 10.4% |
1 Year | -59.23% | 21.5% | 32.6% |
3 Years | -80.85% | 15.7% | 31.0% |
Market Capitalization | 7.8B |
Book Value | $15.8 |
Dividend Share | 1.46 |
Dividend Yield | 11.01% |
Earnings Per Share (EPS) | -6.74 |
PEG Ratio | 3.55 |
Wall Street Target Price | 10.99 |
Profit Margin | -3.99% |
Operating Margin TTM | 0.3% |
Return On Assets TTM | 1.3% |
Return On Equity TTM | -55.97% |
Revenue TTM | 145.5B |
Revenue Per Share TTM | 168.63 |
Quarterly Revenue Growth YOY | 2.6% |
Gross Profit TTM | 27.1B |
EBITDA | 4.0B |
Diluted Eps TTM | -6.74 |
Quarterly Earnings Growth YOY | 1.92 |
EPS Estimate Current Year | 2.85 |
EPS Estimate Next Year | 1.79 |
EPS Estimate Current Quarter | 0.68 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 21.04%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 131.5B | ↑ 11.27% |
Net Income | 5.0B | ↑ 23.2% |
Net Profit Margin | 3.82% | ↑ 0.37% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 136.9B | ↑ 4.05% |
Net Income | 4.0B | ↓ 20.74% |
Net Profit Margin | 2.91% | ↓ 0.91% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 139.5B | ↑ 1.95% |
Net Income | 456.0M | ↓ 88.55% |
Net Profit Margin | 0.33% | ↓ 2.58% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 132.5B | ↓ 5.04% |
Net Income | 1.3B | ↑ 191.23% |
Net Profit Margin | 1.0% | ↑ 0.67% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 132.7B | ↑ 0.15% |
Net Income | 4.3B | ↑ 226.58% |
Net Profit Margin | 3.27% | ↑ 2.27% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 139.1B | ↑ 4.81% |
Net Income | -3.1B | ↓ 171.02% |
Net Profit Margin | -2.21% | ↓ 5.48% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 34.9B | ↑ 4.43% |
Net Income | 537.0M | ↓ 114.05% |
Net Profit Margin | 1.54% | ↑ 12.99% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 35.4B | ↑ 1.59% |
Net Income | -52.0M | ↓ 109.68% |
Net Profit Margin | -0.15% | ↓ 1.69% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 35.4B | ↑ 0.02% |
Net Income | -180.0M | ↑ 246.15% |
Net Profit Margin | -0.51% | ↓ 0.36% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 36.7B | ↑ 3.63% |
Net Income | -67.0M | ↓ 62.78% |
Net Profit Margin | -0.18% | ↑ 0.33% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 37.1B | ↑ 0.94% |
Net Income | -5.9B | ↑ 8717.91% |
Net Profit Margin | -15.95% | ↓ 15.77% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 36.4B | ↓ 1.89% |
Net Income | 344.0M | ↓ 105.82% |
Net Profit Margin | 0.95% | ↑ 16.9% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 68.1B | ↑ 3.2% |
Total Liabilities | 41.4B | ↑ 9.81% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 68.2B | ↑ 0.17% |
Total Liabilities | 43.4B | ↑ 4.85% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 87.2B | ↑ 27.75% |
Total Liabilities | 66.0B | ↑ 52.0% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 81.3B | ↓ 6.76% |
Total Liabilities | 57.5B | ↓ 12.98% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 90.1B | ↑ 10.87% |
Total Liabilities | 59.7B | ↑ 3.92% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 96.6B | ↑ 7.22% |
Total Liabilities | 68.1B | ↑ 14.1% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 100.5B | ↑ 8.19% |
Total Liabilities | 70.9B | ↑ 4.03% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 98.6B | ↓ 1.87% |
Total Liabilities | 69.1B | ↓ 2.53% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 96.6B | ↓ 2.0% |
Total Liabilities | 68.1B | ↓ 1.37% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 97.8B | ↑ 1.24% |
Total Liabilities | 70.1B | ↑ 2.83% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 84.2B | ↓ 13.92% |
Total Liabilities | 68.8B | ↓ 1.75% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 83.0B | ↓ 1.45% |
Total Liabilities | 67.6B | ↓ 1.87% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.3B | ↑ 13.98% |
Investing Cash Flow | -5.5B | ↑ 552.55% |
Financing Cash Flow | -5.3B | ↓ 59.06% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.6B | ↓ 32.32% |
Investing Cash Flow | -2.3B | ↓ 58.06% |
Financing Cash Flow | -3.0B | ↓ 42.46% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.5B | ↓ 1.97% |
Investing Cash Flow | -1.3B | ↓ 43.78% |
Financing Cash Flow | -4.6B | ↑ 52.51% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.6B | ↑ 1.29% |
Investing Cash Flow | 4.1B | ↓ 413.96% |
Financing Cash Flow | -9.0B | ↑ 94.45% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.9B | ↓ 29.81% |
Investing Cash Flow | -1.1B | ↓ 126.13% |
Financing Cash Flow | -1.5B | ↓ 83.41% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.3B | ↓ 42.09% |
Investing Cash Flow | -3.1B | ↑ 190.79% |
Financing Cash Flow | -887.0M | ↓ 40.83% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 746.0M | ↑ 51.32% |
Investing Cash Flow | -5.4B | ↓ 392.84% |
Financing Cash Flow | 2.4B | ↓ 494.82% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -20.0M | ↓ 102.68% |
Investing Cash Flow | 334.0M | ↓ 106.14% |
Financing Cash Flow | -1.2B | ↓ 150.44% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.0B | ↓ 5295.0% |
Investing Cash Flow | 155.0M | ↓ 53.59% |
Financing Cash Flow | -1.5B | ↑ 22.38% |
Sell
Neutral
Buy
Walgreens Boots Alliance, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Walgreens Boots Alliance, Inc. | -0.45% | -53.75% | -60.17% | -81.29% | -82.97% |
Petmed Express Inc | 15.24% | -9.44% | -59.25% | -84.67% | -79.69% |
China Jo-jo Drugstores Inc | 27.74% | -36.22% | -55.0% | -98.68% | -99.32% |
High Tide Inc | 6.13% | -5.86% | 54.11% | -60.6% | -75.0% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Walgreens Boots Alliance, Inc. | 27.42 | NA | 3.55 | 2.85 | -0.56 | 0.01 | 0.11 | 15.8 |
Petmed Express Inc | 1191.0 | NA | 2.58 | -0.19 | -0.03 | 0.0 | NA | 4.56 |
China Jo-jo Drugstores Inc | NA | NA | 0.0 | 0.0 | -0.27 | -0.02 | NA | 8.97 |
High Tide Inc | NA | NA | NA | -0.02 | -0.2 | 0.03 | NA | 1.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Walgreens Boots Alliance, Inc. | Hold | $7.5B | -82.97% | 27.42 | -3.99% |
Petmed Express Inc | Sell | $77.9M | -79.69% | 1191.0 | -0.95% |
China Jo-jo Drugstores Inc | NA | $13.9M | -99.32% | NA | -2.74% |
High Tide Inc | Buy | $181.5M | -75.0% | NA | -5.96% |
Insights on Walgreens Boots Alliance, Inc.
Revenue is down for the last 2 quarters, 37.05B → 36.35B (in $), with an average decrease of 1.9% per quarter
Netprofit is up for the last 2 quarters, -5.90B → 344.0M (in $), with an average increase of 1817.4% per quarter
In the last 1 year, High Tide Inc has given 54.1% return, outperforming this stock by 113.3%
In the last 3 years, Walgreens Boots Alliance, Inc. has experienced a drawdown of -80.8%, however High Tide Inc resisted the overall trend and outperformed by 18.4%
Vanguard Group Inc
BlackRock Inc
State Street Corp
Capital World Investors
Amvescap Plc.
Geode Capital Management, LLC
In the quarter ending March,2024. Walgreens Boots Alliance, Inc. has declared dividend of $0.25
Read Morewalgreens boots alliance is the first global pharmacy-led, health and wellbeing enterprise. the company was created through the combination of walgreens and alliance boots in december 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. the company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the usa and europe. including its equity method investments, walgreens boots alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. the company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, he
Organization | Walgreens Boots Alliance, Inc. |
Employees | 206000 |
CEO | Mr. Stefano Pessina |
Industry | Retail Trade |